SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
APPLIED DNA SCIENCES, INC.
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.50
(Title of Class of Securities)
03815U 10 2
(CUSIP Number)
M. Richard Cutler, 3206 West Wimbledon Drive, Augusta, GA 30909
---------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
May 18, 2005
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the
following box [].
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13D
---------------------------- -----------------
CUSIP NO. 03815U 10 2 PAGE 2 OF 5 PAGES
---------------------------- -----------------
-----------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Paul Aloysius Gerardius Loomans 152559449
-----------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(A) [ ]
(B) [ ]
-----------------------------------------------------------------------
3 SEC USE ONLY
-----------------------------------------------------------------------
4 SOURCE OF FUNDS (See Instructions)
-----------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEM 2(d) or 2(e)
-----------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Netherlands
-----------------------------------------------------------------------
7 SOLE VOTING POWER
526,087
NUMBER OF ----------------------------------------------------------------
SHARES 8 SHARED VOTING POWER
BENEFICIALLY
OWNED BY 3,723,913
EACH ---------------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON
WITH 4,250,000
-------------------------------------------------------
10 SHARED DISPOSITIVE POWER
- 0--
-----------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
4,250,000
-----------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES (See Instructions) [ ]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 10.4% *
14 TYPE OF REPORTING PERSON (See Instructions) IN
--------
*Based upon the Issuer's recent filing on Form SB-2/A. The Reporting Person has
been advised that there are additional
Shares issued by the Issuer subsequent to such report and that consequently the
percentage referenced above may not be
Accurate.
---------------------------- -----------------
CUSIP NO. 03815U 10 2 PAGE 3 OF 5 PAGES
---------------------------- -----------------
ITEM 1. SECURITY AND ISSUER.
This Statement relates to shares of common stock, $0.50 par value per share (the
"Common Stock"), of APPLIED DNA SCIENCES, INC. (the "Corporation"). The
Corporation's principal executive office is located at 9229 Sunset Blvd., suite
805, Los Angeles, CA 90069
ITEM 2. IDENTITY AND BACKGROUND.
(a) This Statement is being filed by Paul Aloysius Gerardus Loomans. (the
"Reporting Person").
(b) The business address of the Reporting Person is:
Brugstraat 42
5731 HH Mierlo
Netherlands
(c) The Reporting Person's present principal occupation is:
Investments
(d) During the last five years, Mr. Loomans has not been convicted in a criminal
proceeding.
(e) During the last five years, Mr. Loomans has not been a party to a civil
proceeding of a judicial or administrative body of competent jurisdiction and as
a result of such proceeding been subject to a judgment, decree or final order
enjoining future violations of, or prohibiting or mandating activities subject
to, federal or state securities law or finding any violation with respect to
such law.
---------------------------- -----------------
CUSIP NO. 03815U 10 2 PAGE 4 OF 5 PAGES
---------------------------- -----------------
(f) The Reporting Person is a citizen of the Netherlands.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
The Reporting Person acquired a total of 526,087 shares of Common Stock of the
Company pursuant to a Stock Purchase Agreement between the Reporting Person and
RHL ManagementThe purchase of such shares was with personal funds.
The Reporting Person also entered into two option agreements with RHL Management
pursuant to which he is entitled to acquire 1,843,071 shares on or before June
25, 2005 at an exercise price of $1.00 per share, and to purchase 1,880,842
shares on or before August 9, 2005 at an exercise price of $1.00 per share.
ITEM 4. PURPOSE OF TRANSACTION.
The Reporting Person does not have any present plan or proposal as a stockholder
which relates to, or would result in any action with respect to, the matters
listed in paragraphs (b) through (j) of Item 4 of Schedule 13D. In the future,
the Reporting Entity may decide to purchase additional shares of Common Stock in
the open market or a private transaction, or to sell any or all of his shares of
Common Stock.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
a) As of April 29, 2004 the Issuer had issued and outstanding a total of
40,012,699 shares of Common Stock as represented in a Registration Statement on
Form SB-2/A. As of that date, the Reporting Person was the beneficial owner of
4,250,000 shares of Common Stock or approximately 10.3% of the issued and
outstanding Common Stock. The Reporting Person has been advised and believes
that additional shares of common stock of the Issuer are outstanding and that
consequently the percentage ownership will be reduced.
(b) The Reporting Person has the sole power to vote, or to direct the vote of,
526,087 shares of Common Stock, shared power to vote an additional 3,723,913
and sole power to dispose of, or to direct the disposition of 4,250,000 shares
of Common Stock. Upon exercise of the options, the Reporting Person would
acquire sole power to vote any and all of such shares.
---------------------------- -----------------
CUSIP NO. 03815U 10 2 PAGE 5 OF 5 PAGES
---------------------------- -----------------
(c) The Reporting Person acquired a total of 526,087 shares of Common Stock of
the Company pursuant to a Stock Purchase Agreement between the Reporting Person
and RHL ManagementThe purchase of such shares was with personal funds.
The Reporting Person also entered into two option agreements with RHL Management
pursuant to which he is entitled to acquire 1,843,071 shares on or before June
25, 2005 at an exercise price of $1.00 per share, and to purchase 1,880,842
shares on or before August 9, 2005 at an exercise price of $1.00 per share.
(d) Not applicable.
(e) Not applicable.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER.
NONE
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
Exhibit 1 Stock Purchase Agreement dated as of May 10, 2005 by and among RHL
Management Corp., Drs. Paul A.G. Loomans FB and Cutler Law Group.
Exhibit 2 Stock Option Agreement dated as of May 10, 2005 by and among RHL
Management Corp., Drs. Paul A.G. Loomans FB and Cutler Law Group.
Exhibit 3 Stock Option Agreement dated as of May 10, 2005 by and among RHL
Management Corp., Drs. Paul A.G. Loomans FB and Cutler Law Group.
SIGNATURE.
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: May 18, 2005
/s/ Paul A G Loomans
Paul Aloysius Gerardus Loomans